Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.

Losa, Marco

Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence. [electronic resource] - The Journal of clinical endocrinology and metabolism 05 2020

Publication Type: Journal Article; Observational Study

1945-7197

10.1210/clinem/dgaa089 doi


Adenoma--epidemiology
Adult
Case-Control Studies
Craniopharyngioma--epidemiology
Female
Follow-Up Studies
Hormone Replacement Therapy--adverse effects
Human Growth Hormone--adverse effects
Humans
Hypophysectomy--adverse effects
Hypopituitarism--drug therapy
Male
Middle Aged
Neoplasm Recurrence, Local--chemically induced
Neurosurgical Procedures--adverse effects
Pituitary Neoplasms--epidemiology
Recombinant Proteins--adverse effects
Retrospective Studies
Risk Factors